NINTEDANIB DOSE ADJUSTMENTS AND ADVERSE EVENTS IN PATIENTS WITH PROGRESSIVE AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES IN THE INBUILD TRIAL - Volkmann, E.; Castellvi, I.; Johnson, S.; Matteson, E.; Distler, Jörg; Seibold, J.; Costabel, U.; James, A.; Coeck, C.; Quaresma, M.; Cottin, V. (ANNALS OF THE RHEUMATIC DISEASES, 2020)
CRIS-Team WoS Importer:2020-08-21